Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 6, 2011, Pages 628-634

  Marin, B ^a,b   Desport, J C ^a,b   Kajeu, P ^a   Jesus, P ^b   Nicolaud, B ^b   Nicol, M ^b   Preux, P M ^a,b   Couratier, Philippe ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; ANALYTICAL PARAMETERS; ARTICLE; BIOIMPEDANCE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FAT FREE MASS; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; HYDRATION; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; MUSCLE EXAMINATION; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PHASE ANGLE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SURVIVAL; WEIGHT REDUCTION;

EID: 79955756864     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.211474     Document Type: Article

References (31)

1. Slowie LA, Paige MS, Antel JP. Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc 1983;83:44-7. (Pubitemid 13072097)
2. Bouteloup C, Desport JC, Clavelou P, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 2009;256:1236-42.
3. Desport JC, Preux PM, Magy L, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2001;74:328-34. (Pubitemid 32802018)
4. Desport JC, Preux PM, Truong TC, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-63. (Pubitemid 29442123)
5. Desport JC, Preux PM, Truong CT, et al. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:91-6.
6. Lo Coco D, Marchese S, Pesco MC, et al. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006;67:761-5. (Pubitemid 44394185)
7. Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008;70:1004-9. (Pubitemid 351451324)
8. World Health Organization Regional Office for Europe. Nutrition and food security. Body Mass Index, 2007. http://www.euro.who.int/nutrition/20030507-1 (accessed 17 Feb 2010).
9. Haute Autorité en Santé. Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée, 2007. http://www.has-sante.fr/portail/ upload/docs/application/pdf/denutrition-personne-agee-2007-recommandations.pdf (accessed 17 Feb 2010).
10. Kasarskis EJ, Berryman S, English T, et al. The use of upper extremity anthropometrics in the clinical assessment of patients with amyotrophic lateral sclerosis. Muscle Nerve 1997;20:330-5. (Pubitemid 27108152)
11. Desport JC, Preux PM, Bouteloup-Demange C, et al. Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2003;77:1179-85. (Pubitemid 44858433)
12. Barbosa-Silva MC, Barros AJ, Wang J, et al. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 2005;82:49-52. (Pubitemid 41716376)
13. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.
14. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998;50:66-72. (Pubitemid 28106021)
15. Kasarskis EJ, Berryman S, Vanderleest JG, et al. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996;63:130-7. (Pubitemid 26005737)
16. Desport JC, Torny F, Lacoste M, et al. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2005;2:202-7. (Pubitemid 43827922)
17. Desport JC, Marin B, Funalot B, et al. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9:273-8.
18. Nau KL, Bromberg MB, Forshew DA, et al. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129(Suppl):47-9.
19. Vaisman N, Lusaus M, Nefussy B, et al. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci 2009;279:26-9.
20. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003;123:1460-6. (Pubitemid 36549763)
21. Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;116:627-36. (Pubitemid 47356347)
22. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005;46:489-500. (Pubitemid 41208185)
23. Dupuis L, Oudart H, Rene F, et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 2004;101:11159-64. (Pubitemid 38989600)
24. Patel BP, Hamadeh MJ. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clin Nutr 2009;28:604-17.
25. Zhao Z, Lange DJ, Voustianiouk A, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 2006;7:29.
26. Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurol 2000;247:245-51. (Pubitemid 30223959)
27. Marin B, Gil J, Preux PM, et al. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997e2007. Amyotroph Lateral Scler 2009;10:216-20.
28. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330:585-91. (Pubitemid 24065791)
29. Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218-26.
30. Chio A, Galletti R, Finocchiaro C, et al. Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry 2004;75:645-7. (Pubitemid 38406671)
31. Andersen PM, Borasio GD, Dengler R, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 2007;8:195-213.